197 related articles for article (PubMed ID: 30235721)
1. Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies.
Yu XY; Xu JL; Li D; Jiang ZF
Medicine (Baltimore); 2018 Sep; 97(38):e12427. PubMed ID: 30235721
[TBL] [Abstract][Full Text] [Related]
2. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
[TBL] [Abstract][Full Text] [Related]
3. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factor for infection of totally implantable venous access port.
Chang TC; Yen MH; Kiu KT
Langenbecks Arch Surg; 2022 Feb; 407(1):343-351. PubMed ID: 34550464
[TBL] [Abstract][Full Text] [Related]
5. Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.
Voog E; Campion L; du Rusquec P; Bourgeois H; Domont J; Denis F; Emmanuel E; Dupuis O; Ganem G; Lafont C; Le Du K; Pavluc E; Pointreau Y; Roche S; Juhel-Voog L; Zinger M; Solal-Celigny P
Support Care Cancer; 2018 Jan; 26(1):81-89. PubMed ID: 28756472
[TBL] [Abstract][Full Text] [Related]
6. Does the Implantation Technique for Totally Implantable Venous Access Ports (TIVAPs) Influence Long-Term Outcome?
Biacchi D; Sammartino P; Sibio S; Accarpio F; Cardi M; Sapienza P; De Cesare A; Atta JM; Impagnatiello A; Di Giorgio A
World J Surg; 2016 Feb; 40(2):284-90. PubMed ID: 26341511
[TBL] [Abstract][Full Text] [Related]
7. Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports-a complication analysis of more than 1000 TIVAP implantations.
Thiel K; Kalmbach S; Maier G; Wichmann D; Schenk M; Königsrainer A; Thiel C
Langenbecks Arch Surg; 2022 Dec; 407(8):3755-3762. PubMed ID: 36070032
[TBL] [Abstract][Full Text] [Related]
8. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
[No Abstract] [Full Text] [Related]
9. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
[TBL] [Abstract][Full Text] [Related]
10. Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center.
Ji L; Yang J; Miao J; Shao Q; Cao Y; Li H
Cell Biochem Biophys; 2015 May; 72(1):235-40. PubMed ID: 25542370
[TBL] [Abstract][Full Text] [Related]
11. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J
J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061
[TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: A systematic review and meta-analysis.
Jiang M; Li CL; Pan CQ; Cui XW; Dietrich CF
J Thromb Haemost; 2020 Sep; 18(9):2253-2273. PubMed ID: 32479699
[TBL] [Abstract][Full Text] [Related]
13. Silver-Mixed Port Reduces Venous Access Port Related Infection Rate Compared to Non-Silver-mixed Port: A Single-center Retrospective Analysis.
Suzuki T; Michimoto K; Hasumi J; Kisaki S; Hasegawa Y; Fujimori A; Yoshimatsu L; Ashida H; Ojiri H
Cardiovasc Intervent Radiol; 2023 Dec; 46(12):1696-1702. PubMed ID: 37902854
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
Lafaurie M; Montlahuc C; Kerneis S; de Lastours V; Abgrall S; Manceron V; Couzigou C; Chabrol A; de Raigniac A; Lescure X; Longuet P; Lesprit P; Vanjak D; Lepeule R;
J Antimicrob Chemother; 2023 May; 78(5):1253-1258. PubMed ID: 37014800
[TBL] [Abstract][Full Text] [Related]
15. A Comparison Between Upper Arm and Chest for Optimal Site of Totally Implanted Venous Access Ports in Patients with Female Breast Cancer.
Yang SS; Ahn MS
Ann Vasc Surg; 2018 Jul; 50():128-134. PubMed ID: 29481918
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of infection of totally implantable venous access port: A retrospective study.
Guan X; Yan H; Zhang J; Li Y; Zhou Y
J Vasc Access; 2023 Nov; 24(6):1340-1348. PubMed ID: 35389296
[TBL] [Abstract][Full Text] [Related]
18. Totally implantable venous-access ports: local problems and extravasation injury.
Kurul S; Saip P; Aydin T
Lancet Oncol; 2002 Nov; 3(11):684-92. PubMed ID: 12424071
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, Safety, and Cost-Effectiveness of Intracavitary Electrocardiography-Guided Catheter Tip Placement for Totally Implantable Venous Access Port.
Liu Z; Zheng X; Zhen Y; Liu X; Lin F; Ye Z; Liu P
Ann Vasc Surg; 2022 Jul; 83():168-175. PubMed ID: 34936891
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-guided totally implantable venous access ports placement via right brachiocephalic vein in pediatric population: A clinical debut.
Ding W; Qiu L; Li T; Su W; Yu Q; Hu T; Wang C; Fan C; Wang W
Pediatr Blood Cancer; 2022 Oct; 69(10):e29911. PubMed ID: 35880972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
